Identification of a CpG island methylator phenotype in adrenocortical carcinomas
- PMID: 23093492
- DOI: 10.1210/jc.2012-2993
Identification of a CpG island methylator phenotype in adrenocortical carcinomas
Abstract
Purpose: DNA methylation is a mechanism for gene expression silencing in cancer. Limited information is available for adrenocortical tumors. Abnormal methylation at the IGF2/H19 locus is common in adrenocortical carcinomas. Our aim was to characterize the methylation in adrenocortical carcinomas at a whole-genome scale and to assess its clinical significance and its impact on gene expression.
Experimental design: Methylation patterns of CpG islands in promoter regions of 51 adrenocortical carcinomas and 84 adenomas were studied by the Infinium HumanMethylation27 Beadchip (Illumina, San Diego, CA). Methylation of 33 genes was studied by methylation-specific multiplex ligation-dependent probe amplification (MRC-Holland, Amsterdam, The Netherlands) in 15 carcinomas. Gene expression data were available for 87 tumors from a previous study (HG-U133Plus2.0 AffymetrixGeneChip; Affymetrix, Santa Clara, CA). Clinical information, including patient features and survival, were available for all tumors.
Results: Methylation was higher in carcinomas than in adenomas (t test P = 3.1 × 10(-9)). Unsupervised clustering of DNA methylation profiles identified two groups of carcinomas, one with an elevated methylation level, evoking a CpG island methylator phenotype (CIMP). The subgroup of hypermethylated carcinomas was further divided in two subgroups, with different levels of methylation (CIMP-high and CIMP-low). This classification could be confirmed by methylation-specific multiplex ligation-dependent probe amplification. Hypermethylation was associated with a poor survival (Cox model P = 0.02). The transcriptome/methylation correlation showed 1741 genes (of 12,250) negatively correlated; among the top genes were H19 and other tumor suppressors (PLAGL-1, G0S2, and NDRG2).
Conclusions: This genome-wide methylation analysis reveals the existence of hypermethylated adrenocortical carcinomas, with a poorer prognosis. Hypermethylation in these tumors is important for silencing specific tumor suppressor genes.
Comment in
-
CpG island methylator phenotype in adrenocortical carcinoma: fact or fiction?J Clin Endocrinol Metab. 2013 Jan;98(1):48-50. doi: 10.1210/jc.2012-4063. J Clin Endocrinol Metab. 2013. PMID: 23293338 Free PMC article. No abstract available.
Similar articles
-
Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.Genes Chromosomes Cancer. 2012 Oct;51(10):949-60. doi: 10.1002/gcc.21978. Epub 2012 Jun 26. Genes Chromosomes Cancer. 2012. PMID: 22733721
-
CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.Clin Cancer Res. 2006 May 15;12(10):2995-3002. doi: 10.1158/1078-0432.CCR-05-1601. Clin Cancer Res. 2006. PMID: 16707594
-
The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158. Mol Cancer Res. 2008. PMID: 18403637
-
Biological significance of the CpG island methylator phenotype.Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):35-42. doi: 10.1016/j.bbrc.2014.07.007. Epub 2014 Jul 10. Biochem Biophys Res Commun. 2014. PMID: 25016183 Review.
-
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.Eur J Endocrinol. 2016 Jun;174(6):R249-65. doi: 10.1530/EJE-15-1118. Epub 2016 Jan 6. Eur J Endocrinol. 2016. PMID: 26739091 Review.
Cited by
-
Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma.Endocr Connect. 2020 Jul;9(7):705-714. doi: 10.1530/EC-20-0228. Endocr Connect. 2020. PMID: 32698135 Free PMC article.
-
Advances in translational research of the rare cancer type adrenocortical carcinoma.Nat Rev Cancer. 2023 Dec;23(12):805-824. doi: 10.1038/s41568-023-00623-0. Epub 2023 Oct 19. Nat Rev Cancer. 2023. PMID: 37857840 Review.
-
Recent advances on the role of G0S2.Discov Oncol. 2025 Jul 18;16(1):1362. doi: 10.1007/s12672-025-03198-4. Discov Oncol. 2025. PMID: 40679675 Free PMC article. Review.
-
Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.Oncotarget. 2015 Apr 10;6(10):8210-25. doi: 10.18632/oncotarget.3601. Oncotarget. 2015. PMID: 25823664 Free PMC article.
-
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.JAMA Oncol. 2019 Oct 1;5(10):1440-1447. doi: 10.1001/jamaoncol.2019.1558. JAMA Oncol. 2019. PMID: 31294750 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous